Clinical Trial Update: Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics of the investigational compound PMC-309 in patients with solid tumors that ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PMC-309

Snippet

Sponsor: PharmAbcine | Conditions: Advanced or Metastatic Solid Tumors | Phase 1 | Status: RECRUITING